PulteGroup Overview
Is PHM undervalued? Intrinsic value estimate stands at $140.
Get informed when a big investor buys or sells
+ Follow$136.58
Undervalued by 14.0% based on the discounted cash flow analysis.
The latest DCF fair value for PHM is $140. Investors often review this figure alongside PulteGroup's historical trend and sector peers before judging valuation or financial health.
A DCF fair value of $140 for PulteGroup suggests the stock may be undervalued by roughly 14.0% at today's price. That does not mean the market is 'wrong'; it means the model's cash-flow assumptions imply a different intrinsic value. Stress-test the estimate by comparing it with historical valuation ranges and peer multiples.
After noting PHM's DCF fair value ($140), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack PulteGroup's DCF fair value against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
